Publications tagged with “safety”
Quantifying any risk associated with using specific medications or treatments.
- Maro JC, Wiley M, Cole DV, et al. High throughput signal identification of drug use in pregnancy for detection of adverse infant outcomes. Podium presented at: 2024 International Society for Pharmacoepidemiology Annual Meeting; Aug 24 – Aug 28, 2024; Berlin, DE .
- Forshee R, Smith ER, Wan Z, et al. Evaluation of febrile seizure risk following ancestral monovalent COVID-19 mrna vaccination among U.S. children aged 2-5 years. Podium presented at: 2024 International Society for Pharmacoepidemiology Annual Meeting; Aug 24 – Aug 28, 2024; Berlin, DE .
- Anthony MS, Djebarri L, Beachler DC, et al. Risk of anaphylaxis among new users of glucagon-like peptide-1 receptor agonists (GLP-1 ras). Poster presented at: 2023 American Diabetes Association Scientific Sessions; Jun 23 – Jun 26, 2023; San Diego, CA, US https://diabetesjournals.org/diabetes/article/72/Supplement_1/846-P/150217/846-P-Risk-of-Anaphylaxis-among-New-Users-of. doi: 10.2337/db23-846-P.
- Anthony MS, Aroda VR, Parlett LE, et al. Risk of anaphylaxis among new users of GLP-1 receptor agonists: a cohort study. Diabetes Care. 2024; 47 (4) :712-9 doi: 10.2337/dc23-1911.